Quanome Technologies, Inc.

Quanome Technologies, Inc.

Overview

Quanome Technologies, Inc. is a Nevada holding company with primary operations conducted through subsidiaries in the PRC and the Cayman Islands. The company focuses on three areas:

• Pharmaceutical distribution through Hupan Pharmaceutical (PRC).
• Strategic development of quantum-related technologies via Quantum Nexus (Cayman Islands).
• Early-stage AI compute capacity and managed inference services through XDT Infrastructure I, LLC (Delaware), intended to run on company-owned hardware.

Key corporate actions in 2026:

• February 12, 2026: Disposed of the U.S. cross-border logistics operation (ABL Chicago).
• August 3, 2026: Changed name from Lakeside Holding Limited to Quanome Technologies, Inc.
• August 4, 2026: Began trading on the Nasdaq Capital Market under ticker QNME.
• August–September 2026: Quantum Nexus activities started and advisory frameworks were announced.
• September 2026: XDT Infrastructure I, LLC commenced AI compute and managed inference services operations.

Key business lines

1) Pharmaceutical distribution — Hupan Pharmaceutical

• Role: Midstream distributor between pharmaceutical manufacturers and hospitals, distributors, and healthcare providers. The business does not perform manufacturing.
• Product categories: Infusion products, foods for special medical purposes, and specialty pharmaceuticals.
• Sales model: Primarily sales agents who handle customer development, order coordination, and account management. Procurement cycles and hospital/regional bidding affect revenue timing.
• Scale: Revenue recognized from more than 60 customers; approximately four customers each represented over 10% of total revenue (as of June 30, 2026).
• Licensing and approvals: Operates under PRC distributor licenses, including Drug Business License, Medical Device Business License, Class II Medical Device Filing Certificate, and Food Business License.
• Market exposure and risks: Concentration among top customers, procurement cycle sensitivity, government price controls and policy changes, competitive pressures, and potential regulatory changes affecting licenses or permitted activities.

2) AI compute capacity and managed inference services — XDT Infrastructure I, LLC

• Model: Provision of dedicated compute capacity and managed inference services for AI workloads using company-owned servers. Services can be offered on dedicated (physically segregated) or shared infrastructure.
• Service scope: Infrastructure operation and hosting, model deployment support, API access, monitoring, and related technical services. Service outputs reflect the customer’s results; performance or token/latency guarantees require explicit agreement.
• Stage: Early development; no executed customer contracts or revenue reported as of the reporting date.
• Hardware: Agreement in place to purchase 32 servers built for high-performance AI workloads.
• Dependencies and risks: Export controls, data protection, cybersecurity, hardware costs and availability, and third-party supplier dependencies that can affect deployment and pricing.

3) Quantum-related technologies and applications — Quantum Nexus

• Vehicle: Quantum Nexus (Cayman Islands) is focused on opportunities in quantum computing, post-quantum cryptography, and related technologies.
• Stage: Development and evaluation phase; advisory structures established to support opportunity identification and collaboration.
• Advisory framework: Global Quantum Council and Scientific Advisory Network announced to formalize relationships and explore partnerships or investments.
• Commercialization risk: Initiative is exploratory with no definitive commercial agreements at this time.

Corporate structure and geographic footprint

• Holding company: Quanome Technologies, Inc. (Nevada). Headquarters listed in New York, NY.
• PRC operations: Hupan Pharmaceutical (wholly owned through Sichuan Hupan, the intermediate holding company).
• Cayman Islands entities: Smart Reserve Holding Ltd., Smart Reserve Inc., Quantum Nexus Technologies Ltd.
• Delaware entities: XDT Infrastructure I, LLC (and related XDT US HoldCo, LLC; XDT Infrastructure II, LLC).
• Employees and funding (as of June 30, 2026):
  • Total full-time employees: 27.
  • Aggregate funding provided to PRC subsidiaries: approximately US$12.7 million.
  • Primary executive office: 112 W 34th St, 18th Floor, New York, NY 10120.
• Public listing: Nasdaq Capital Market under ticker QNME (effective August 4, 2026).

Financial and operational highlights

• Pharmaceutical distribution: Revenue recognized from more than 60 customers, with four customers each accounting for over 10% of revenue (as of June 30, 2026).
• AI and quantum activities: Both initiatives are in development or evaluation stages and had not generated revenue as of the reporting date.
• Workforce: 27 full-time employees across functions.

Licensing, regulatory, and compliance considerations

• PRC distribution licenses: Operates under applicable PRC licenses for drug, medical device, and food distribution; renewals or scope changes may affect operations.
• Data protection and export controls: PRC data protection, cybersecurity, and export control considerations apply, particularly as the company expands into AI and quantum technologies.
• Cross-border and financial regulations: Foreign exchange controls and restrictions on remitting earnings from PRC subsidiaries may affect cross-border transfers and distributions. Potential regulatory filings related to HFCAA or CSRC requirements could apply to future offerings.
• Export control risks: AI hardware and related technologies may be subject to U.S. export control regimes; ongoing compliance and due diligence are required for cross-border transactions.

Summary

Quanome Technologies operates a PRC-based pharmaceutical distribution business while developing AI infrastructure services and quantum technology initiatives. The pharmaceutical distribution business is active and serves a broad customer base. The AI and quantum programs are in early stages and focused on development, evaluation, and building advisory and technical frameworks. The company completed a name change and Nasdaq listing in 2026, employs 27 full-time staff, and has provided funding to its PRC subsidiaries to support operations and growth.